新辅助化疗对自体与假体即刻乳房再造术后手术结局的影响:系统综述与Meta分析
该系统综述与Meta分析纳入8项研究共51,731例患者,其中5161例接受新辅助化疗(NACT)、46,570例未接受。NACT未显著增加再造失败、皮瓣坏死、再手术或伤口并发症风险;假体再造亚组中单期直接植入假体(DTI)假体失败率显著低于两期组织扩张器/假体(TE/I),但该关联需进一步评估。
要点
- NACT未显著增加即刻乳房再造的主要或次要并发症发生率。
- 假体再造亚组中DTI假体失败率显著低于TE/I(RR=0.43)。
- DTI与TE/I的关联需进一步评估。
核心结论
- NACT未增加自体组织或假体即刻乳房再造的主要或次要并发症发生率,NACT与即刻乳房再造应被视为安全的手术。
- 假体再造亚组分析提示单期DTI较两期TE/I更安全,但该关联需进一步评估。
研究设计与样本
- 系统综述与Meta分析,检索PubMed与EMBASE,纳入评估NACT对即刻乳房再造主要与次要并发症影响的研究。
- 共纳入8项研究、51,731例患者,其中5161例接受NACT,46,570例未接受NACT。
主要发现
- 主要并发症方面,NACT未显著增加再造失败率(RR=1.35,95%CI 0.96-1.91,p=0.09)。
- NACT未显著增加乳房切除皮瓣坏死率(RR=1.39,95%CI 0.61-3.17,p=0.44)。
- NACT未显著增加再手术率(RR=1.09,95%CI 0.87-1.37,p=0.45)。
- 次要并发症方面,NACT未显著增加伤口并发症率(RR=1.05,95%CI 0.87-1.28,p=0.62)。
- 假体再造亚组中,单期DTI的假体失败率显著低于两期TE/I(RR=0.43,95%CI 0.26-0.71,p=0.0011)。
关键数值与推荐
- 主要效应量为相对风险(RR)、95%置信区间(95%CI)与p值。
- 假体再造亚组:DTI vs TE/I的假体失败RR=0.43(95%CI 0.26-0.71,p=0.0011)。
临床怎么用
- 作者认为NACT与即刻乳房再造应被视为安全的手术。
- 作者指出假体再造亚组分析提示单期DTI较两期TE/I更安全,但该关联需进一步评估。
局限性
- 作者指出DTI与TE/I的关联需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of neoadjuvant chemotherapy (NACT) on the complication rate after implant-based and autologous breast reconstruction remains unclear. The aim of this study was to systematically review and perform a meta-analysis of previously published studies on immediate breast reconstruction (IBR) in breast cancer patients treated with NACT compared with controls. METHODS: PubMed and EMBASE were searched to identify studies assessing the impact of NACT on major and minor complications after IBR. The primary effect measures were relative risk (RR), 95% confidence interval (95% CI), and p-value. RESULTS: Eight studies comprising 51,731 patients were included in the meta-analysis. Of these, 5161 patients received NACT and 46,570 patients did not receive NACT. In regard to major complications, NACT did not statistically significant increase the rate of reconstructive failure (RR = 1.35, 95% CI = 0.96-1.91, p = 0.09), the rate of mastectomy skin-flap necrosis (RR = 1.39, 95% CI = 0.61-3.17, p = 0.44), or the rate of reoperation (RR = 1.09, 95% CI = 0.87-1.37, p = 0.45). Regarding minor complications, NACT did not significantly increase the rate of wound complications (RR = 1.05, 95% CI = 0.87-1.28, p = 0.62). In a subgroup analysis of implant-based breast reconstruction following NACT, single-stage direct-to-implant (DTI) had a significantly lower implant failure rate compared with two-staged tissue expander/implant (TE/I) (RR = 0.43, 95% CI = 0.26-0.71, p = 0.0011). CONCLUSION: NACT did not increase the major or minor complication rate after IBR with either autologous tissue or implants. Thus, NACT and IBR should be considered safe procedures. The review of studies describing patients undergoing implant-based breast reconstruction following NACT could indicate that single-stage DTI was a safer procedure than two-staged TE/I. However, the association requires further evaluation.
引用
- Sabitovic A, Trøstrup H, Damsgaard TE, et al. The impact of neoadjuvant chemotherapy on surgical outcomes following autologous and implant-based immediate breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37804643. doi:10.1016/j.bjps.2023.09.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。